Phaseline

Targets › CXCR5

CXCR5 (C-X-C chemokine receptor type 5): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 2; Hematology.

Cytokine receptor that binds to B-lymphocyte chemoattractant (BLC). Involved in B-cell migration into B-cell follicles of spleen and Peyer patches but not into those of mesenteric or peripheral lymph nodes. (UniProt, P32302)

Open in Phaseline: the race on CXCR5, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
PfizerPF-06835375
CXCR5 inhibitor
CXCR5Phase 2Primary Immune Thrombocytopenia–

Conditions

Primary Immune Thrombocytopenia (1)

Modalities

protein or peptide (1)

Companies

Pfizer (1)

Related targets

–

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.